U.S. markets closed

Athersys, Inc. (ATHX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.6400+0.0100 (+0.61%)
At close: 4:00PM EDT

1.6300 -0.01 (-0.61%)
After hours: 5:07PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Triple Moving Average Crossover

Triple Moving Average Crossover

Previous Close1.6300
Open1.6300
Bid1.6100 x 3200
Ask1.6500 x 3200
Day's Range1.5800 - 1.6500
52 Week Range1.5300 - 3.3900
Volume2,158,889
Avg. Volume3,238,477
Market Cap353.002M
Beta (5Y Monthly)-1.67
PE Ratio (TTM)N/A
EPS (TTM)-0.4200
Earnings DateMay 06, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Athersys to Host First Quarter Financial Results Call
    Business Wire

    Athersys to Host First Quarter Financial Results Call

    Athersys, Inc. will host its first quarter 2021 financial results call on Thursday, May 6, 2021 at 4:30 PM EDT.

  • Athersys to Present at the Needham Virtual Healthcare Conference on April 14
    Business Wire

    Athersys to Present at the Needham Virtual Healthcare Conference on April 14

    Athersys will present a corporate overview at the 20th Annual Needham Virtual Healthcare Conference on April 14th and the event will be webcast.

  • Why Athersys Stock Jumped Today
    Motley Fool

    Why Athersys Stock Jumped Today

    What happened Shares of Athersys (NASDAQ: ATHX) were jumping 10.9% higher as of 3:17 p.m. EDT on Wednesday. The solid gain came after the company announced that its partner Healios completed enrollment in a clinical study being conducted in Japan evaluating regenerative stem cell therapy candidate MultiStem in treating acute respiratory distress syndrome (ARDS) caused by pneumonia.